Nystatin A3

Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.

Cross Reference

Introduction

To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Nystatin A3?

Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Nystatin A3

MeSH term MeSH ID Detail
AIDS-Related Opportunistic Infections D017088 9 associated lipids
Urethritis D014526 9 associated lipids
Candidiasis, Vulvovaginal D002181 8 associated lipids
Blastomycosis D001759 5 associated lipids
Candidemia D058387 2 associated lipids
Per page 10 20 50 | Total 25

PubChem Associated disorders and diseases

What pathways are associated with Nystatin A3

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Nystatin A3?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Nystatin A3?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Nystatin A3?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Nystatin A3?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Nystatin A3?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Nystatin A3

Download all related citations
Per page 10 20 50 100 | Total 1594
Authors Title Published Journal PubMed Link
Chanteloup NK et al. The extra-intestinal avian pathogenic Escherichia coli strain BEN2908 invades avian and human epithelial cells and survives intracellularly. 2011 Vet. Microbiol. pmid:20708353
Rushing EC et al. Iatrogenic oral hairy leukoplakia: report of two cases. 2011 J. Cutan. Pathol. pmid:21121942
Berger J et al. Evidence for basolateral Cl- channels as modulators of apical Cl- secretion in pulmonary epithelia of Xenopus laevis. 2011 Am. J. Physiol. Regul. Integr. Comp. Physiol. pmid:21123756
Day TP et al. Imbuing aqueous solubility to amphotericin B and nystatin with a vitamin. 2011 Mol. Pharm. pmid:21141891
Schwan C et al. Cholesterol- and sphingolipid-rich microdomains are essential for microtubule-based membrane protrusions induced by Clostridium difficile transferase (CDT). 2011 J. Biol. Chem. pmid:21705797
Huang CY et al. Cutaneous hyalohyphomycosis caused by Paecilomyces lilacinus successfully treated by oral voriconazole and nystatin packing. 2011 Mycopathologia pmid:21424606
Mane RS et al. Synthesis of an adenine nucleoside containing the (8'R) epimeric carbohydrate core of amipurimycin and its biological study. 2011 J. Org. Chem. pmid:21381774
Woods O and Saliba I Effect of nystatin on Guinea Pigs' inner ear. 2011 Neurotox Res pmid:21384237
Shahidi-Noghabi S et al. Internalization of Sambucus nigra agglutinins I and II in insect midgut CF-203 cells. 2011 Arch. Insect Biochem. Physiol. pmid:21254203
Jeon HG et al. Analysis and functional expression of NPP pathway-specific regulatory genes in Pseudonocardia autotrophica. 2011 J. Ind. Microbiol. Biotechnol. pmid:21259033
Wu D et al. Traditional Chinese formula, lubricating gut pill, stimulates cAMP-dependent CI(−) secretion across rat distal colonic mucosa. 2011 J Ethnopharmacol pmid:21195154
Orce G et al. β-Cyclodextrin and permeability to water in the bladder of Bufo arenarum. 2011 Can. J. Physiol. Pharmacol. pmid:21609275
Messier C and Grenier D Effect of licorice compounds licochalcone A, glabridin and glycyrrhizic acid on growth and virulence properties of Candida albicans. 2011 Mycoses pmid:21615543
Acar A et al. Comparison of silver-coated dressing (Acticoat®), chlorhexidine acetate 0.5% (Bactigrass®) and nystatin for topical antifungal effect in Candida albicans-contaminated, full-skin-thickness rat burn wounds. 2011 Burns pmid:21354707
Villa NY et al. Phylogenetic and preliminary phenotypic analysis of yeast PAQR receptors: potential antifungal targets. 2011 J. Mol. Evol. pmid:22009226
Fan SR and Liu XP In vitro fluconazole and nystatin susceptibility and clinical outcome in complicated vulvovaginal candidosis. 2011 Mycoses pmid:20406393
Aydemir C et al. Randomised controlled trial of prophylactic fluconazole versus nystatin for the prevention of fungal colonisation and invasive fungal infection in very low birth weight infants. 2011 Arch. Dis. Child. Fetal Neonatal Ed. pmid:20659937
Frey Tirri B Antimicrobial topical agents used in the vagina. 2011 Curr. Probl. Dermatol. pmid:21325838
Xu L et al. [Cisplatin enhances TRAIL-induced apoptosis in gastric cancer cells through clustering death receptor 4 into lipid rafts]. 2011 Zhonghua Zhong Liu Za Zhi pmid:22093622
Pupe CG et al. Preparation and evaluation of antimicrobial activity of nanosystems for the control of oral pathogens Streptococcus mutans and Candida albicans. 2011 Int J Nanomedicine pmid:22114490
Brautaset T et al. New nystatin-related antifungal polyene macrolides with altered polyol region generated via biosynthetic engineering of Streptomyces noursei. 2011 Appl. Environ. Microbiol. pmid:21764946
Chao TY and Raines RT Mechanism of ribonuclease A endocytosis: analogies to cell-penetrating peptides. 2011 Biochemistry pmid:21827164
Sakeer K et al. Use of xanthan and its binary blends with synthetic polymers to design controlled release formulations of buccoadhesive nystatin tablets. 2010 Jul-Aug Pharm Dev Technol pmid:19772376
Peacock G et al. Accuracy and precision of manufacturer-supplied liquid medication administration devices before and after patient education. 2010 Jan-Feb J Am Pharm Assoc (2003) pmid:20097644
Yap FB et al. Penicillium marneffei infection in an African man. 2010 Dermatol. Online J. pmid:20673530
Sakeer K et al. Enhancement of dissolution of nystatin from buccoadhesive tablets containing various surfactants and a solid dispersion formulation. 2010 Arch. Pharm. Res. pmid:21116780
Raghu H et al. Localization of uPAR and MMP-9 in lipid rafts is critical for migration, invasion and angiogenesis in human breast cancer cells. 2010 BMC Cancer pmid:21106094
Schilling T and Eder C Importance of lipid rafts for lysophosphatidylcholine-induced caspase-1 activation and reactive oxygen species generation. 2010 Cell. Immunol. pmid:20832779
Tempark T et al. Exogenous Cushing's syndrome due to topical corticosteroid application: case report and review literature. 2010 Endocrine pmid:20972726
Kolter R Biofilms in lab and nature: a molecular geneticist's voyage to microbial ecology. 2010 Int. Microbiol. pmid:20890834
Violaris K et al. Comparison of fluconazole and nystatin oral suspensions for prophylaxis of systemic fungal infection in very low birthweight infants. 2010 Am J Perinatol pmid:19504425
López-Martínez R Candidosis, a new challenge. 2010 Clin. Dermatol. pmid:20347660
te Welscher YM et al. Natamycin inhibits vacuole fusion at the priming phase via a specific interaction with ergosterol. 2010 Antimicrob. Agents Chemother. pmid:20385867
Ogita A et al. Targeted yeast vacuole disruption by polyene antibiotics with a macrocyclic lactone ring. 2010 Int. J. Antimicrob. Agents pmid:19910165
de Aguiar MM et al. Oral sustained release nystatin tablets for the treatment of oral candidiasis: formulation development and validation of UV spectrophotometric analytical methodology for content determination. 2010 Drug Dev Ind Pharm pmid:19954405
Preobrazhenskaya MN et al. Synthesis and study of the antifungal activity of new mono- and disubstituted derivatives of a genetically engineered polyene antibiotic 28,29-didehydronystatin A1 (S44HP). 2010 J. Antibiot. pmid:19960041
Bílková E et al. Targeted antifungal delivery system: beta-glucosidase sensitive nystatin-star poly(ethylene glycol) conjugate. 2010 Int J Pharm pmid:19874880
Field EA Discontinuation concern. 2010 Br Dent J pmid:20448592
Böckle BC et al. Oral mucous squamous cell carcinoma-an anticipated consequence of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED). 2010 J. Am. Acad. Dermatol. pmid:20304522
Mete E et al. Synthesis and antifungal activity of 1-aryl-3-phenethylamino-1-propanone hydrochlorides and 3-aroyl-4-aryl-1-phenethyl-4-piperidinols. 2010 Arch. Pharm. (Weinheim) pmid:20232370
Shamsul HM et al. The Toll-like receptor 2 (TLR2) ligand FSL-1 is internalized via the clathrin-dependent endocytic pathway triggered by CD14 and CD36 but not by TLR2. 2010 Immunology pmid:20113368
Dalben-Dota KF et al. Antifungal activity of propolis extract against yeasts isolated from vaginal exudates. 2010 J Altern Complement Med pmid:20192913
Samaranayake YH et al. The post-antifungal effect (PAFE) of amphotericin B, nystatin, ketoconazole and 5-fluorocytosine and its impact on the colonization traits of Candida glabrata. 2010 Med. Mycol. pmid:20092419
Martínez-Beneyto Y et al. Use of antifungal agents for oral candidiasis: results of a national survey. 2010 Int J Dent Hyg pmid:20096082
Semis R et al. Nystatin-intralipid preparation: characterization and in vitro activity against yeasts and molds. 2010 Mycopathologia pmid:20069459
Ulrych A et al. Dissociation of nystatin and amphotericin analogues: characterisation of minor anti-fungal macrolides. 2010 Eur J Mass Spectrom (Chichester, Eng) pmid:20065516
Young JP et al. Acetylsalicylic acid enhances purinergic receptor-mediated outward currents in rat megakaryocytes. 2010 Am. J. Physiol., Cell Physiol. pmid:20042731
González-Damián J and Ortega-Blake I Effect of membrane structure on the action of polyenes II: nystatin activity along the phase diagram of ergosterol- and cholesterol-containing POPC membranes. 2010 J. Membr. Biol. pmid:20871987
Récamier KS et al. Effect of membrane structure on the action of polyenes: I. Nystatin action in cholesterol- and ergosterol-containing membranes. 2010 J. Membr. Biol. pmid:20872217
Bernbeck B et al. Long time survival after reduced chemotherapy ina 15-year-old patient with AML and Candida krusei sepsis and eye involvement. 2009 Nov-Dec Klin Padiatr pmid:19890793